{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:14:29Z","timestamp":1758273269375,"version":"3.41.2"},"reference-count":90,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780128234686"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/bs.enz.2021.06.003","type":"book-chapter","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T09:40:59Z","timestamp":1634895659000},"page":"63-82","source":"Crossref","is-referenced-by-count":7,"title":["HCV RdRp, sofosbuvir and beyond"],"prefix":"10.1016","member":"78","reference":[{"issue":"2","key":"10.1016\/bs.enz.2021.06.003_bb0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrgastro.2016.176","article-title":"Global epidemiology and burden of HCV infection and HCV-related disease","volume":"14","author":"Thrift","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/bs.enz.2021.06.003_bb0015","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cld.2017.03.012","article-title":"Economic burden of hepatitis C infection","volume":"21","author":"Stepanova","year":"2017","journal-title":"Clin. Liver Dis."},{"issue":"1","key":"10.1016\/bs.enz.2021.06.003_bb0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/nyas.12832","article-title":"Development of sofosbuvir for the treatment of hepatitis C virus infection","volume":"1358","author":"Lawitz","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"18","key":"10.1016\/bs.enz.2021.06.003_bb0025","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1517\/14656566.2013.850074","article-title":"Simeprevir for the treatment of chronic hepatitis C","volume":"14","author":"You","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"issue":"5386","key":"10.1016\/bs.enz.2021.06.003_bb0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.282.5386.103","article-title":"Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy","volume":"282","author":"Neumann","year":"1998","journal-title":"Science"},{"issue":"10","key":"10.1016\/bs.enz.2021.06.003_bb0035","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3390\/v12101090","article-title":"Delayed by design: role of suboptimal signal peptidase processing of viral structural protein precursors in Flaviviridae virus assembly","volume":"12","author":"Alzahrani","year":"2020","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/bs.enz.2021.06.003_bb0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/viro.1996.8357","article-title":"Hepatitis C virus NS5B protein is a membrane-associated phosphoprotein with a predominantly perinuclear localization","volume":"227","author":"Hwang","year":"1997","journal-title":"Virology"},{"issue":"1","key":"10.1016\/bs.enz.2021.06.003_bb0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/bbrc.1997.6249","article-title":"Expression, purification, and partial characterization of HCV RNA polymerase","volume":"232","author":"Yuan","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/bs.enz.2021.06.003_bb0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/j.1460-2075.1996.tb00329.x","article-title":"Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus","volume":"15","author":"Behrens","year":"1996","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/bs.enz.2021.06.003_bb0055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/viro.1998.9311","article-title":"Biochemical and kinetic analyses of NS5B RNA-dependent RNA polymerase of the hepatitis C virus","volume":"249","author":"Lohmann","year":"1998","journal-title":"Virology"},{"issue":"4","key":"10.1016\/bs.enz.2021.06.003_bb0060","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.510290448","article-title":"Expression of hepatitis C virus NS5B protein: characterization of its RNA polymerase activity and RNA binding","volume":"29","author":"Ishii","year":"1999","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/bs.enz.2021.06.003_bb0065","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1128\/JVI.74.2.851-863.2000","article-title":"De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus","volume":"74","author":"Luo","year":"2000","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/bs.enz.2021.06.003_bb0070","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2893.2000.00218.x","article-title":"Biochemical and structural analysis of the NS5B RNA-dependent RNA polymerase of the hepatitis C virus","volume":"7","author":"Lohmann","year":"2000","journal-title":"J. Viral Hepat."},{"issue":"11","key":"10.1016\/bs.enz.2021.06.003_bb0075","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1021\/bi051483s","article-title":"Biochemical and pre-steady-state kinetic characterization of the hepatitis C virus RNA polymerase (NS5BDelta21, HC-J4)","volume":"45","author":"Cramer","year":"2006","journal-title":"Biochemistry"},{"issue":"18","key":"10.1016\/bs.enz.2021.06.003_bb0080","doi-asserted-by":"crossref","first-page":"13685","DOI":"10.1074\/jbc.M109.082206","article-title":"Mechanisms of activity and inhibition of the hepatitis C virus RNA-dependent RNA polymerase","volume":"285","author":"Reich","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/bs.enz.2021.06.003_bb0085","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1074\/jbc.274.5.2706","article-title":"Poliovirus RNA-dependent RNA polymerase (3Dpol) is sufficient for template switching in vitro","volume":"274","author":"Arnold","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/bs.enz.2021.06.003_bb0090","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1002\/j.1460-2075.1995.tb00299.x","article-title":"A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus","volume":"14","author":"Garcin","year":"1995","journal-title":"EMBO J."},{"issue":"1762","key":"10.1016\/bs.enz.2021.06.003_bb0095","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2018.0162","article-title":"Terminal nucleotidyl transferases (TENTs) in mammalian RNA metabolism","volume":"373","author":"Warkocki","year":"2018","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"9","key":"10.1016\/bs.enz.2021.06.003_bb0100","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.1128\/jvi.68.9.5811-5818.1994","article-title":"Identification of terminal adenylyl transferase activity of the poliovirus polymerase 3Dpol","volume":"68","author":"Neufeld","year":"1994","journal-title":"J. Virol."},{"issue":"18","key":"10.1016\/bs.enz.2021.06.003_bb0105","doi-asserted-by":"crossref","first-page":"8615","DOI":"10.1128\/JVI.75.18.8615-8623.2001","article-title":"Terminal nucleotidyl transferase activity of recombinant Flaviviridae RNA-dependent RNA polymerases: implication for viral RNA synthesis","volume":"75","author":"Ranjith-Kumar","year":"2001","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/bs.enz.2021.06.003_bb0110","doi-asserted-by":"crossref","first-page":"8416","DOI":"10.1128\/jvi.71.11.8416-8428.1997","article-title":"Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity","volume":"71","author":"Lohmann","year":"1997","journal-title":"J. Virol."},{"issue":"41","key":"10.1016\/bs.enz.2021.06.003_bb0115","doi-asserted-by":"crossref","first-page":"38838","DOI":"10.1074\/jbc.M204657200","article-title":"Modulation of hepatitis C virus RNA-dependent RNA polymerase activity by structure-based site-directed mutagenesis","volume":"277","author":"Labonte","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/bs.enz.2021.06.003_bb0120","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1006\/viro.2001.0948","article-title":"A novel mechanism to ensure terminal initiation by hepatitis C virus NS5B polymerase","volume":"285","author":"Hong","year":"2001","journal-title":"Virology"},{"issue":"25","key":"10.1016\/bs.enz.2021.06.003_bb0125","doi-asserted-by":"crossref","first-page":"15479","DOI":"10.1074\/jbc.273.25.15479","article-title":"RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region","volume":"273","author":"Yamashita","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"Pt 3","key":"10.1016\/bs.enz.2021.06.003_bb0130","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1099\/0022-1317-81-3-759","article-title":"Biochemical characterization of a hepatitis C virus RNA-dependent RNA polymerase mutant lacking the C-terminal hydrophobic sequence","volume":"81","author":"Tomei","year":"2000","journal-title":"J. Gen. Virol."},{"issue":"32","key":"10.1016\/bs.enz.2021.06.003_bb0135","doi-asserted-by":"crossref","first-page":"10579","DOI":"10.1021\/bi049773g","article-title":"Enzymatic characterization of the full-length and C-terminally truncated hepatitis C virus RNA polymerases: function of the last 21 amino acids of the C terminus in template binding and RNA synthesis","volume":"43","author":"Vo","year":"2004","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/bs.enz.2021.06.003_bb0140","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/JVI.73.2.1649-1654.1999","article-title":"Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli","volume":"73","author":"Ferrari","year":"1999","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/bs.enz.2021.06.003_bb0145","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1128\/JVI.76.8.3865-3872.2002","article-title":"Oligomerization and cooperative RNA synthesis activity of hepatitis C virus RNA-dependent RNA polymerase","volume":"76","author":"Wang","year":"2002","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/bs.enz.2021.06.003_bb0150","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1074\/jbc.M106880200","article-title":"Oligomeric interaction of hepatitis C virus NS5B is critical for catalytic activity of RNA-dependent RNA polymerase","volume":"277","author":"Qin","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/bs.enz.2021.06.003_bb0155","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1128\/jvi.69.3.1575-1581.1995","article-title":"Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing","volume":"69","author":"Tanji","year":"1995","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/bs.enz.2021.06.003_bb0160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/bbrc.1998.8202","article-title":"Complex formation of NS5B with NS3 and NS4A proteins of hepatitis C virus","volume":"244","author":"Ishido","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/bs.enz.2021.06.003_bb0165","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1006\/viro.1999.9893","article-title":"Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein","volume":"263","author":"Tu","year":"1999","journal-title":"Virology"},{"issue":"43","key":"10.1016\/bs.enz.2021.06.003_bb0170","doi-asserted-by":"crossref","first-page":"36417","DOI":"10.1074\/jbc.M508175200","article-title":"Hepatitis C virus nonstructural protein 5A (NS5A) is an RNA-binding protein","volume":"280","author":"Huang","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/bs.enz.2021.06.003_bb0175","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.febslet.2008.12.016","article-title":"Hepatitis C virus NS5A protein modulates template selection by the RNA polymerase in in vitro system","volume":"583","author":"Ivanov","year":"2009","journal-title":"FEBS Lett."},{"issue":"48","key":"10.1016\/bs.enz.2021.06.003_bb0180","doi-asserted-by":"crossref","first-page":"50031","DOI":"10.1074\/jbc.M408617200","article-title":"Protein kinase C-related kinase 2 regulates hepatitis C virus RNA polymerase function by phosphorylation","volume":"279","author":"Kim","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/bs.enz.2021.06.003_bb0185","doi-asserted-by":"crossref","first-page":"10807","DOI":"10.1074\/jbc.274.16.10807","article-title":"Selective stimulation of hepatitis C virus and pestivirus NS5B RNA polymerase activity by GTP","volume":"274","author":"Lohmann","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"43","key":"10.1016\/bs.enz.2021.06.003_bb0190","doi-asserted-by":"crossref","first-page":"32906","DOI":"10.1074\/jbc.M110.151316","article-title":"Further insights into the roles of GTP and the C terminus of the hepatitis C virus polymerase in the initiation of RNA synthesis","volume":"285","author":"Harrus","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/bs.enz.2021.06.003_bb0195","doi-asserted-by":"crossref","first-page":"7694","DOI":"10.1128\/JVI.73.9.7694-7702.1999","article-title":"A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA","volume":"73","author":"Oh","year":"1999","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/bs.enz.2021.06.003_bb0200","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1006\/bbrc.2000.2120","article-title":"De novo RNA synthesis catalyzed by HCV RNA-dependent RNA polymerase","volume":"268","author":"Sun","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/bs.enz.2021.06.003_bb0205","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1128\/JVI.74.4.2017-2022.2000","article-title":"De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase","volume":"74","author":"Zhong","year":"2000","journal-title":"J. Virol."},{"issue":"28","key":"10.1016\/bs.enz.2021.06.003_bb0210","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1021\/bi991992s","article-title":"Only a small fraction of purified hepatitis C RNA-dependent RNA polymerase is catalytically competent: implications for viral replication and in vitro assays","volume":"39","author":"Carroll","year":"2000","journal-title":"Biochemistry"},{"issue":"22","key":"10.1016\/bs.enz.2021.06.003_bb0215","doi-asserted-by":"crossref","first-page":"11926","DOI":"10.1128\/JVI.01008-09","article-title":"Structural and functional analysis of hepatitis C virus strain JFH1 polymerase","volume":"83","author":"Simister","year":"2009","journal-title":"J. Virol."},{"issue":"13","key":"10.1016\/bs.enz.2021.06.003_bb0220","doi-asserted-by":"crossref","first-page":"10674","DOI":"10.1074\/jbc.M111.325530","article-title":"Assembly, purification, and pre-steady-state kinetic analysis of active RNA-dependent RNA polymerase elongation complex","volume":"287","author":"Jin","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/bs.enz.2021.06.003_bb0225","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0969-2126(00)80031-3","article-title":"Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus","volume":"7","author":"Ago","year":"1999","journal-title":"Structure"},{"issue":"23","key":"10.1016\/bs.enz.2021.06.003_bb0230","doi-asserted-by":"crossref","first-page":"13034","DOI":"10.1073\/pnas.96.23.13034","article-title":"Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus","volume":"96","author":"Bressanelli","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/bs.enz.2021.06.003_bb0235","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/13305","article-title":"Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site","volume":"6","author":"Lesburg","year":"1999","journal-title":"Nat. Struct. Biol."},{"issue":"16","key":"10.1016\/bs.enz.2021.06.003_bb0240","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.1074\/jbc.M116.760579","article-title":"Biochemical characterization and structure determination of a potent, selective antibody inhibitor of human MMP9","volume":"292","author":"Appleby","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/bs.enz.2021.06.003_bb0245","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1128\/AAC.00186-07","article-title":"Pyrophosphorolytic excision of nonobligate chain terminators by hepatitis C virus NS5B polymerase","volume":"51","author":"Deval","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/bs.enz.2021.06.003_bb0250","doi-asserted-by":"crossref","first-page":"8743","DOI":"10.1016\/S0021-9258(18)52937-9","article-title":"Human immunodeficiency virus reverse transcriptase. A kinetic analysis of RNA-dependent and DNA-dependent DNA polymerization","volume":"268","author":"Reardon","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/bs.enz.2021.06.003_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmb.2004.01.030","article-title":"Excision of incorporated nucleotide analogue chain-terminators can diminish their inhibitory effects on viral RNA-dependent RNA polymerases","volume":"337","author":"D'Abramo","year":"2004","journal-title":"J. Mol. Biol."},{"issue":"23","key":"10.1016\/bs.enz.2021.06.003_bb0260","doi-asserted-by":"crossref","first-page":"13471","DOI":"10.1073\/pnas.95.23.13471","article-title":"Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism","volume":"95","author":"Meyer","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"18","key":"10.1016\/bs.enz.2021.06.003_bb0265","doi-asserted-by":"crossref","first-page":"9143","DOI":"10.1128\/JVI.76.18.9143-9151.2002","article-title":"Nucleoside analog resistance caused by insertions in the fingers of human immunodeficiency virus type 1 reverse transcriptase involves ATP-mediated excision","volume":"76","author":"Boyer","year":"2002","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/bs.enz.2021.06.003_bb0270","doi-asserted-by":"crossref","first-page":"E348","DOI":"10.1073\/pnas.1214924110","article-title":"NTP-mediated nucleotide excision activity of hepatitis C virus RNA-dependent RNA polymerase","volume":"110","author":"Jin","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"14","key":"10.1016\/bs.enz.2021.06.003_bb0275","doi-asserted-by":"crossref","first-page":"11979","DOI":"10.1074\/jbc.M210914200","article-title":"Inhibition of hepatitis C virus RNA replication by 2\u2032-modified nucleoside analogs","volume":"278","author":"Carroll","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/bs.enz.2021.06.003_bb0280","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1128\/AAC.00032-11","article-title":"Inhibition of hepatitis C virus replicon RNA synthesis by PSI-352938, a cyclic phosphate prodrug of beta-D-2\u2032-deoxy-2\u2032-alpha-fluoro-2\u2032-beta-C-methylguanosine","volume":"55","author":"Lam","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/bs.enz.2021.06.003_bb0285","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1128\/AAC.02351-13","article-title":"Inhibition of hepatitis C virus replication by GS-6620, a potent C-nucleoside monophosphate prodrug","volume":"58","author":"Feng","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl A","key":"10.1016\/bs.enz.2021.06.003_bb0290","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jac\/32.suppl_A.121","article-title":"Antivirals for the treatment of herpesvirus infections","volume":"32","author":"De Clercq","year":"1993","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/bs.enz.2021.06.003_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2014.04.005","article-title":"Nucleoside\/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance","volume":"8","author":"Menendez-Arias","year":"2014","journal-title":"Curr. Opin. Virol."},{"issue":"1","key":"10.1016\/bs.enz.2021.06.003_bb0300","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2009.09.014","article-title":"Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine","volume":"85","author":"Cihlar","year":"2010","journal-title":"Antiviral Res."},{"issue":"2","key":"10.1016\/bs.enz.2021.06.003_bb0305","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/AAC.00400-06","article-title":"Mechanism of activation of beta-D-2\u2032-deoxy-2\u2032-fluoro-2\u2032-c-methylcytidine and inhibition of hepatitis C virus NS5B RNA polymerase","volume":"51","author":"Murakami","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"45","key":"10.1016\/bs.enz.2021.06.003_bb0310","doi-asserted-by":"crossref","first-page":"34337","DOI":"10.1074\/jbc.M110.161802","article-title":"Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977","volume":"285","author":"Murakami","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/bs.enz.2021.06.003_bb0315","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1021\/jm100863x","article-title":"Discovery of a beta-d-2\u2032-deoxy-2\u2032-alpha-fluoro-2\u2032-beta-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus","volume":"53","author":"Sofia","year":"2010","journal-title":"J. Med. Chem."},{"issue":"5394","key":"10.1016\/bs.enz.2021.06.003_bb0320","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1126\/science.282.5394.1669","article-title":"Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance","volume":"282","author":"Huang","year":"1998","journal-title":"Science"},{"issue":"12","key":"10.1016\/bs.enz.2021.06.003_bb0325","doi-asserted-by":"crossref","first-page":"7705","DOI":"10.1074\/jbc.M709563200","article-title":"Structural insights into mechanisms of catalysis and inhibition in Norwalk virus polymerase","volume":"283","author":"Zamyatkin","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"6223","key":"10.1016\/bs.enz.2021.06.003_bb0330","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1126\/science.1259210","article-title":"Viral replication. Structural basis for RNA replication by the hepatitis C virus polymerase","volume":"347","author":"Appleby","year":"2015","journal-title":"Science"},{"issue":"49","key":"10.1016\/bs.enz.2021.06.003_bb0335","doi-asserted-by":"crossref","first-page":"49164","DOI":"10.1074\/jbc.M305041200","article-title":"Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro","volume":"278","author":"Migliaccio","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"26","key":"10.1016\/bs.enz.2021.06.003_bb0340","doi-asserted-by":"crossref","first-page":"23616","DOI":"10.1074\/jbc.M101114200","article-title":"Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma","volume":"276","author":"Lim","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"44","key":"10.1016\/bs.enz.2021.06.003_bb0345","doi-asserted-by":"crossref","first-page":"40847","DOI":"10.1074\/jbc.M106743200","article-title":"Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase","volume":"276","author":"Johnson","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/bs.enz.2021.06.003_bb0350","first-page":"E662","article-title":"Probing the structural and molecular basis of nucleotide selectivity by human mitochondrial DNA polymerase gamma [correction]","volume":"113","author":"Sohl","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/bs.enz.2021.06.003_bb0355","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/labinvest.3780288","article-title":"Mitochondrial dna depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors","volume":"81","author":"Lewis","year":"2001","journal-title":"Lab. Invest."},{"key":"10.1016\/bs.enz.2021.06.003_bb0360","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.fct.2015.09.008","article-title":"Amanita phalloides poisoning: mechanisms of toxicity and treatment","volume":"86","author":"Garcia","year":"2015","journal-title":"Food Chem. Toxicol."},{"issue":"11","key":"10.1016\/bs.enz.2021.06.003_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003030","article-title":"Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral Ribonucleosides","volume":"8","author":"Arnold","year":"2012","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/bs.enz.2021.06.003_bb0370","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00492-17","article-title":"Nucleotide substrate specificity of anti-hepatitis C virus nucleoside analogs for human mitochondrial RNA polymerase","volume":"61","author":"Ehteshami","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/bs.enz.2021.06.003_bb0375","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1128\/AAC.01922-15","article-title":"Role of mitochondrial RNA polymerase in the toxicity of nucleotide inhibitors of hepatitis C virus","volume":"60","author":"Feng","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/bs.enz.2021.06.003_bb0380","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1016\/j.bmcl.2012.04.065","article-title":"Synthesis and characterization of 2'-C-me branched C-nucleosides as HCV polymerase inhibitors","volume":"22","author":"Cho","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"10.1016\/bs.enz.2021.06.003_bb0385","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1021\/jm400201a","article-title":"Discovery of the first C-nucleoside HCV polymerase inhibitor (GS-6620) with demonstrated antiviral response in HCV infected patients","volume":"57","author":"Cho","year":"2014","journal-title":"J. Med. Chem."},{"issue":"6232","key":"10.1016\/bs.enz.2021.06.003_bb0390","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1126\/science.aaa3778","article-title":"Infectious disease. Combating emerging viral threats","volume":"348","author":"Bekerman","year":"2015","journal-title":"Science"},{"issue":"5","key":"10.1016\/bs.enz.2021.06.003_bb0395","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/acs.jmedchem.6b01594","article-title":"Discovery and synthesis of a Phosphoramidate prodrug of a Pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses","volume":"60","author":"Siegel","year":"2017","journal-title":"J. Med. Chem."},{"issue":"7594","key":"10.1016\/bs.enz.2021.06.003_bb0400","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"issue":"396","key":"10.1016\/bs.enz.2021.06.003_bb0405","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-Spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/bs.enz.2021.06.003_bb0410","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00221-18","article-title":"Coronavirus susceptibility to the antiviral Remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease","volume":"9","author":"Agostini","year":"2018","journal-title":"MBio"},{"issue":"37","key":"10.1016\/bs.enz.2021.06.003_bb0415","doi-asserted-by":"crossref","first-page":"E3900","DOI":"10.1073\/pnas.1323705111","article-title":"One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities","volume":"111","author":"Subissi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/bs.enz.2021.06.003_bb0420","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.1073\/pnas.1718806115","article-title":"Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA","volume":"115","author":"Ferron","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.enz.2021.06.003_bb0425","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/v11040326","article-title":"Mechanism of inhibition of Ebola virus RNA-dependent RNA polymerase by Remdesivir","volume":"11","author":"Tchesnokov","year":"2019","journal-title":"Viruses"},{"issue":"15","key":"10.1016\/bs.enz.2021.06.003_bb0430","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1074\/jbc.AC120.013056","article-title":"The antiviral compound Remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/bs.enz.2021.06.003_bb0435","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.RA120.013679","article-title":"Remdesivir is a direct-acting antiviral that inhibits RNA dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"47","key":"10.1016\/bs.enz.2021.06.003_bb0440","doi-asserted-by":"crossref","first-page":"16156","DOI":"10.1074\/jbc.AC120.015720","article-title":"Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action","volume":"295","author":"Tchesnokov","year":"2020","journal-title":"Journal of Biological Chemistry (JBC)"},{"issue":"4","key":"10.1016\/bs.enz.2021.06.003_bb0445","doi-asserted-by":"crossref","first-page":"e02479","DOI":"10.1128\/AAC.02479-20","article-title":"AT-527, a double prodrug of a guanosine nucleotide analog, is a potent inhibitor of SARS-CoV-2 in vitro and a promising oral antiviral for treatment of COVID-19","volume":"65","author":"Good","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"541","key":"10.1016\/bs.enz.2021.06.003_bb0450","doi-asserted-by":"crossref","first-page":"eabb5883","DOI":"10.1126\/scitranslmed.abb5883","article-title":"An orally bioavailable broad-Spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice","volume":"12","author":"Sheahan","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/bs.enz.2021.06.003_bb0455","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41564-020-00835-2","article-title":"Therapeutically administered ribonucleoside analogue MK-4482\/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets","volume":"6","author":"Cox","year":"2021","journal-title":"Nat. Microbiol."}],"container-title":["The Enzymes","Viral Replication Enzymes and their Inhibitors Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604721000032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604721000032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:17:46Z","timestamp":1753888666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874604721000032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780128234686"],"references-count":90,"URL":"https:\/\/doi.org\/10.1016\/bs.enz.2021.06.003","relation":{},"ISSN":["1874-6047"],"issn-type":[{"type":"print","value":"1874-6047"}],"subject":[],"published":{"date-parts":[[2021]]}}}